Invesco Ltd. Instil Bio, Inc. Transaction History

Invesco Ltd.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.6 - $0.91 $976 - $1,481	-1,628 Reduced 7.86%	19,091 $12,000
Q4 2022 Feb 13, 2023	SELL	$0.48 - $5.33 $96 - $1,071	-201 Reduced 0.96%	20,719 $13,000
Q3 2022 Nov 14, 2022	SELL	$4.65 - $7.37 $795 - $1,260	-171 Reduced 0.81%	20,920 $101,000
Q2 2022 Aug 15, 2022	SELL	$4.21 - $11.15 $9,535 - $25,254	-2,265 Reduced 9.7%	21,091 $97,000
Q1 2022 May 16, 2022	BUY	$8.48 - $18.1 $9,387 - $20,036	1,107 Added 4.98%	23,356 $251,000
Q4 2021 Feb 14, 2022	BUY	$15.37 - $22.5 $341,967 - $500,602	22,249 New	22,249 $381,000

1.9M

Ticker TIL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 129,694,000
Market Cap $2.82B
Description
Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.